Journals / Güncel Retina Dergisi / 2018 / Cilt: 2 - Sayı: 2

Surgical Therapy in Diabetic Macular Edema and Diabetic Intravitreal Hemorrhage

Diyabetik Maküla Ödeminde ve Diyabetik Vitre İçi Hemorajide Cerrahi Tedavi

Pages
194–201
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, changes in the timing of surgery in diabetic intravitreal hemorrhage since DRVS and risk factors and the efficacy of preventive measures for postvitrectomy intravitreal hemorrhage will be discussed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetic macular edema and diabetic intravitreal hemorrhage are frequent complications of diabetes.
📊
Key Findings & Data:In selected cases of diabetic macular edema which is primarily treated with intravitreal injections surgery may be performed.
💡
Conclusion & Impact:Moreover, changes in the timing of surgery in diabetic intravitreal hemorrhage since DRVS and risk factors and the efficacy of preventive measures for postvitrectomy intravitreal hemorrhage will be discussed
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diabetic macular edema and diabetic intravitreal hemorrhage are frequent complications of diabetes. In selected cases of diabetic macular edema which is primarily treated with intravitreal injections surgery may be performed. In this review the role of surgery in diabetic macular edema will be discussed in light of the current literature. Moreover, changes in the timing of surgery in diabetic intravitreal hemorrhage since DRVS and risk factors and the efficacy of preventive measures for postvitrectomy intravitreal hemorrhage will be discussed

Özet

Diyabetik maküla ödemi ve diyabetik vitre içi hemoraji diyabetin sık karşılaşılan komplikasyonlarıdır. Primer olarak intravitreal enjeksiyonlar ile tedavi edilen diyabetik maküla ödeminde seçilmiş olgularda cerrahi uygulanabilmektedir. Bu derlemede güncel literatür ışığında diyabetik maküla ödeminde cerrahinin rolü tartışılacaktır. Ayrıca diyabetik vitre içi hemorajide DRVS'den (Diabetic Retinopathy Vitrectomy Study) bu yana cerrahi zamanlamada olan değişiklikler ve postvitrektomi vitre hemoraji gelişimi risk faktörleri ve engellemeye yönelik girişimlerin etkinliği tartışılacaktır

🔖

Cite This Article

DURUKAN, A. H., KÜÇÜKEVCİLİOĞLU, M., ERDURMAN, F. C. (2018). Surgical Therapy in Diabetic Macular Edema and Diabetic Intravitreal Hemorrhage. Güncel Retina Dergisi, Cilt: 2 - Sayı: 2, 194–201. https://ajindex.com/articles/215433

References (10)

  1. Lewis H, Abrams GW, Blumenkranz MS, Campo RV. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 1992;99(5):753-759
  2. Nasrallah FP et al. The role of the vitreous in diabetic macular edema. Ophthalmology. 1988;95(10):1335-1339
  3. Hikichi T, Fujio N, Akiba J, Azuma Y, Takahashi M, Yoshida A. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology. 1997;104(3):473-478
  4. Bhagat N, Grigorian RA, Tutela A, Zarbin MA. Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol. 2009;54(1):1-32
  5. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol. 2001;158(1):147-152
  6. Recchia FM, Ruby AJ, Carvalho Recchia CA. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol. 2005;139(3):447-454
  7. Laidlaw DA. Vitrectomy for diabetic macular oedema. Eye (Lond). 2008;22(10):1337-1341
  8. Chin HS, Park TS, Moon YS, Oh JH. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina. 2005;25(5):556-560
  9. Ahn J et al. Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes. J Ocul Pharmacol Ther. 2013;29(7):612-618
  10. Ahn SJ et al. Intraocular pharmacokinetics of ranibizumab in vitrectomized versus nonvitrectomized eyes. Invest Ophthalmol Vis Sci. 2014;55(1):567- 573. 11-Chang-Lin JE et al. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci. 2011;52(7):4605-4609. 12-Patel AK. Surgical treatment of diabetic macular edema. Retinal Physician. 2013;10:16-24. 13-Diabetic Retinopathy Clinical Research Network Writing Committee, Haller JA et al. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction. Ophthalmology. 2010;117(6):1087-1093.e3. 14-Gentile RC, Milman T, Eliott D, Romero JM, McCormick SA. Taut internal limiting membrane causing diffuse diabetic macular edema after vitrectomy: clinicopathological correlation. Ophthalmologica. 2011;226(2):64-70. 15-Yanyali A, Nohutcu AF, Horozoglu F, Celik E. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabe